Status:
COMPLETED
Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1)
Lead Sponsor:
Versailles Hospital
Conditions:
COVID
Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
The main objective of this retrospective clinical epidemiology study is to describe the characteristics of Covid-19 cases requiring hospitalization in adult patients with lymphomas during the initial ...
Detailed Description
I Methods : * Multicentric retrospective observational epidemiological study based on the collection of data from patient records. * Selection of voluntary hospital sites in regions with excess mort...
Eligibility Criteria
Inclusion
- Patients at least 18 years of age with lymphoma and a diagnosis of Covid-19 requiring hospitalization.
- In order not to bias the data by excluding patients with adverse outcomes, we will also collect data from deceased patients.
Exclusion
- Patients who refused to participate
- \-
Key Trial Info
Start Date :
May 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2020
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT04386512
Start Date
May 15 2020
End Date
July 15 2020
Last Update
August 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CH de Versailles
Le Chesnay, France